James Elvecrog

455 total citations
6 papers, 254 citations indexed

About

James Elvecrog is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, James Elvecrog has authored 6 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in James Elvecrog's work include Immunotherapy and Immune Responses (4 papers), Immune Response and Inflammation (2 papers) and Amoebic Infections and Treatments (2 papers). James Elvecrog is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Immune Response and Inflammation (2 papers) and Amoebic Infections and Treatments (2 papers). James Elvecrog collaborates with scholars based in United States, Netherlands and Switzerland. James Elvecrog's co-authors include Mark A. Tomai, Ashenafi Y. Tilahun, John P. Vasilakos, Christopher B. Fox, Iwen F. Grigsby, Robert W. Wilkinson, Ronald Herbst, Andrew J. Leishman, Stefanie Mullins and John G. Swales and has published in prestigious journals such as Cancer Research, Journal of Controlled Release and Journal of Pharmaceutical Sciences.

In The Last Decade

James Elvecrog

6 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Elvecrog United States	5	193	81	61	39	23	6	254
Wandang Wang China	8	184 1.0×	72 0.9×	45 0.7×	71 1.8×	56 2.4×	16	303
Tennille D. Thelen United States	10	135 0.7×	39 0.5×	50 0.8×	66 1.7×	22 1.0×	10	307
Michelle Sue Jann Lee Japan	12	182 0.9×	33 0.4×	102 1.7×	39 1.0×	33 1.4×	15	329
Lorna Rettig Switzerland	7	245 1.3×	100 1.2×	142 2.3×	33 0.8×	14 0.6×	7	361
Koji Ozasa Japan	8	210 1.1×	38 0.5×	138 2.3×	59 1.5×	35 1.5×	10	313
Yuko Shirai Japan	9	155 0.8×	37 0.5×	40 0.7×	18 0.5×	27 1.2×	13	264
Andreas Palmborg Sweden	7	191 1.0×	81 1.0×	96 1.6×	29 0.7×	34 1.5×	12	260
Kailan Sierra-Davidson United States	3	197 1.0×	103 1.3×	71 1.2×	55 1.4×	61 2.7×	9	356
Ruby White United States	9	114 0.6×	60 0.7×	41 0.7×	19 0.5×	20 0.9×	17	307
Lijia Wu China	10	82 0.4×	117 1.4×	58 1.0×	46 1.2×	14 0.6×	26	269

Countries citing papers authored by James Elvecrog

Since Specialization

Citations

This map shows the geographic impact of James Elvecrog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Elvecrog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Elvecrog more than expected).

Fields of papers citing papers by James Elvecrog

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Elvecrog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Elvecrog. The network helps show where James Elvecrog may publish in the future.

Co-authorship network of co-authors of James Elvecrog

This figure shows the co-authorship network connecting the top 25 collaborators of James Elvecrog. A scholar is included among the top collaborators of James Elvecrog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Elvecrog. James Elvecrog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Mullins, Stefanie, John P. Vasilakos, Katharina Deschler, et al.. (2019). Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies. Journal for ImmunoTherapy of Cancer. 7(1). 244–244. 137 indexed citations

2.

Abhyankar, Mayuresh M., Mark T. Orr, Susan Lin, et al.. (2018). Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica. npj Vaccines. 3(1). 22–22. 28 indexed citations

3.

Mullins, Stefanie, John P. Vasilakos, Katharina Deschler, et al.. (2018). Abstract 711: Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies. Cancer Research. 78(13_Supplement). 711–711. 1 indexed citations

4.

Abhyankar, Mayuresh M., Zannatun Noor, Mark A. Tomai, et al.. (2017). Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica. Vaccine. 35(6). 916–922. 21 indexed citations

5.

Fakhari, Amir, James Elvecrog, John P. Vasilakos, et al.. (2017). Thermosensitive Gel–Based Formulation for Intratumoral Delivery of Toll-Like Receptor 7/8 Dual Agonist, MEDI9197. Journal of Pharmaceutical Sciences. 106(8). 2037–2045. 23 indexed citations

6.

Fox, Christopher B., Mark T. Orr, Neal Van Hoeven, et al.. (2016). Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach. Journal of Controlled Release. 244(Pt A). 98–107. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact